
|Articles|November 1, 2012
LNG-IUS may have potential in endometrial cancer
Insertion of a levonorgestrel intrauterine system (LNG-IUS) can reverse abnormal endometrial cell growth, according to the results of a small study in high-risk patients, suggesting that the device may have potential in treatment of women with early-stage endometrial cancer who are not candidates for surgery.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS
2
PMOS Awareness Month: Watch our expert panel discussion on PMOS
3
Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling
4
Positively Pregnant tool helps patients time home pregnancy testing
5






